FWP
CVS icon

FAS Wealth Partners’s CVS Health CVS Stock Holding History

FAS Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,182
Closed -$220K – 417
2023
Q2 		$220K Buy
3,182
+15
+0.5% +$1.07K 0.03% 245
2023
Q1 		$235K Hold
3,167
– – 0.03% 258
2022
Q4 		$295K Sell
3,167
-688
-18% -$66.4K 0.03% 242
2022
Q3 		$368K Buy
3,855
+437
+13% +$43.3K 0.04% 205
2022
Q2 		$317K Buy
3,418
+1,029
+43% +$100K 0.03% 228
2022
Q1 		$242K Buy
2,389
+4
+0.2% +$420 0.02% 255
2021
Q4 		$246K Sell
2,385
-607
-20% -$56.1K 0.02% 265
2021
Q3 		$254K Buy
+2,992
New +$251K 0.02% 259
2021
Q1 		– Sell
-4,085
Closed -$279K – 348
2020
Q4 		$279K Buy
+4,085
New +$266K 0.03% 217

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FAS Wealth Partners's CVS Position: Q3 2023 in Review

FAS Wealth Partners sold out of CVS Health (CVS) in Q3 2023, closing a stake of 3,182 shares — an estimated $220K sold.

FAS Wealth Partners first reported a position in CVS in Q4 2020 and held it in 9 quarters. The position peaked at $368K in Q3 2022. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • FAS Wealth Partners reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • FAS Wealth Partners sold 3,182 CVS Health shares in Q3 2023, an estimated $220K.
  • FAS Wealth Partners first reported a position in CVS Health in Q4 2020 and held it in 9 quarters.
  • FAS Wealth Partners's CVS Health position peaked at $368K in Q3 2022.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on FAS Wealth Partners's 13F filing for Q3 2023, filed 23 Oct 2023.